EUVIMEDEUVIMED entdecken
Crossref

Role of Inflammation in Atherosclerosis: Emerging Biomarkers and Therapeutic Targets

Journal of Pathology and Diagnostic Microbiology · 2024 · 1

DOI: 10.59462/jpdm.1.1.102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pathology and Diagnostic Microbiology, 2024.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activat ed immune cells, cytokines, and adhesion mol ecules perpetuate vascular injury, driving dis ease progression. Recent advances highlight novel inflammatory biomarkers that improve risk prediction beyond traditional lipid profiles. Fur thermore, targeting inflammation offers promis ing therapeutic avenues for preventing adverse cardiovascular events. Understanding inflam mation’s central role is thus critical for identify ing emerging biomarkers and developing inno vative treatment strategies in atherosclerosis. The study highlights inflammation as a central mechanism in the initiation and progression of atherosclerosis. Findings reveal that pro-inflam matory cytokines, immune cell infiltration, and endothelial dysfunction collectively drive plaque development and instability. Emerging biomark ers such as high-sensitivity C-reactive protein, interleukins, and adhesion molecules demon strate strong predictive value for cardiovascular risk beyond traditional lipid measures. More over, therapeutic strategies targeting inflamma tion, including monoclonal antibodies and an ti-cytokine agents, show promising outcomes in reducing adverse cardiovascular events. These results emphasize the potential of integrating inflammatory biomarkers into clinical practice and advancing anti-inflammatory therapies as novel approaches to managing atherosclerotic cardiovascular disease. Inflammation is a pivot al driver of atherosclerosis, influencing plaque initiation, progression, and rupture. Emerging biomarkers provide valuable insights for early detection and risk stratification, while novel an ti-inflammatory therapies show potential in re ducing cardiovascular events. Integrating these advances into clinical practice could revolutionize prevention and treatment strategies. Contin ued research is essential to validate biomarkers and optimize therapeutic targets, ultimately im proving outcomes in patients with atherosclerotic cardiovascular disease.

Zitieren

APA

(2024). Role of Inflammation in Atherosclerosis: Emerging Biomarkers and Therapeutic Targets. Journal of Pathology and Diagnostic Microbiology, 1. https://doi.org/10.59462/jpdm.1.1.102

Vancouver

Role of Inflammation in Atherosclerosis: Emerging Biomarkers and Therapeutic Targets. Journal of Pathology and Diagnostic Microbiology. 2024;1. doi:10.59462/jpdm.1.1.102

BibTeX
@article{euvimed2024,
  title = {Role of Inflammation in Atherosclerosis: Emerging Biomarkers and Therapeutic Targets},
  journal = {Journal of Pathology and Diagnostic Microbiology},
  year = {2024},
  volume = {1},
  doi = {10.59462/jpdm.1.1.102}
}
Kostenlos starten →